Detalhe da pesquisa
1.
Effect of inbreeding on intellectual disability revisited by trio sequencing.
Clin Genet
; 95(1): 151-159, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315573
2.
Predictors of poor responsiveness in physical rehabilitation centers in Tehran.
Med J Islam Repub Iran
; 33: 18, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31380308
3.
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.
Hum Psychopharmacol
; 31(2): 103-12, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856695
4.
Cross Cultural Adaptation and Psychometric Evaluation of the Short Version of Smart Phone Addiction Scale in the Persian Language.
Iran J Psychiatry
; 18(1): 35-44, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159639
5.
Comparison of Caregivers' Burden among Family Members of Patients with Severe Mental Disorders and Patients with Substance Use Disorder.
Iran J Psychiatry
; 18(2): 183-190, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37383957
6.
Evaluating the Effects of Experiencing Virtual Reality Simulation of Psychosis on Mental Illness Stigma, Empathy, and Knowledge in Medical Students.
Front Psychiatry
; 13: 880331, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35656349
7.
Income-Related Inequality in Traffic Accident Health Outcomes (Injury, Disability and Mortality): Evidence from the Nationwide Survey in Iran.
Iran J Public Health
; 49(4): 718-726, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32548052
8.
Prevalence and Socio-Economic Determinants of Disabilities Caused by Road Traffic Accidents in Iran; A National Survey.
Bull Emerg Trauma
; 7(1): 60-66, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719468
9.
The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
Asian J Psychiatr
; 45: 44-49, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493624
10.
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry
; 32(3): 726-32, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18096287
11.
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Hum Psychopharmacol
; 23(2): 79-86, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17972359
12.
Responsiveness of Physical Rehabilitation Centers in Capital of Iran: Disparities and Related Determinants in Public and Private Sectors.
Front Public Health
; 6: 317, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488030
13.
Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial.
J Psychiatr Res
; 94: 70-77, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28688338
14.
Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.
J Psychiatr Res
; 75: 24-30, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26800392
15.
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
Acta Med Iran
; 53(6): 337-45, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069170
16.
The DSM-5 Levels of Personality Functioning and Severity of Iranian Patients With Antisocial and Borderline Personality Disorders.
Iran Red Crescent Med J
; 17(8): e19885, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26430521
17.
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.
Psychopharmacology (Berl)
; 231(3): 533-42, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24013610
18.
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
Psychiatry Res
; 215(3): 540-6, 2014 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24480077
19.
Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
J Psychiatr Res
; 47(4): 472-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23375406
20.
N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.
Clin Neuropharmacol
; 36(6): 185-92, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24201233